In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis

Tiziana Bonifacino, Francesca Provenzano, Elena Gallia, Silvia Ravera, Carola Torazza, Simone Bossi, Sara Ferrando, Aldamaria Puliti, Ludo Van Den Bosch, Giambattista Bonanno, Marco Milanese

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1 <sup>G93A</sup> mouse model of amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences